Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity
- 22 January 2022
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 40 (7) , 875-890
Abstract
No abstract availableKeywords
Funding Information
- ALSAM Foundation
- American Foundation for Pharmaceutical Education
- Huntsman Cancer Institute, University of Utah
- National Comprehensive Cancer Network (63285843, CD229)
This publication has 108 references indexed in Scilit:
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T CellsClinical Cancer Research, 2013
- Exploring the Dynamic Range of the Kinetic Exclusion Assay in Characterizing Antigen-Antibody InteractionsPLOS ONE, 2012
- Fast on-rates allow short dwell time ligands to activate T cellsProceedings of the National Academy of Sciences, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Complete but curtailed T-cell response to very low-affinity antigenNature, 2009
- T‐cell receptor binding affinities and kinetics: impact on T‐cell activity and specificityImmunology, 2009
- Mammalian Cell Display for Antibody Engineering2008
- Isolation of human monoclonal antibodies by mammalian cell displayProceedings of the National Academy of Sciences, 2008
- Computational design of antibody-affinity improvement beyond in vivo maturationNature Biotechnology, 2007
- Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinityProceedings of the National Academy of Sciences, 2006